Navigation Links
Rational Design of Modified Release Dosage Forms: From Pharmacokinetic Targets Through Technology Selection, new life science webinar hosted by Xtalks
Date:8/27/2013

Toronto, Canada (PRWEB) August 27, 2013

Designing dosage forms that allow for more effective drug delivery and release is critical for success in both the clinic and marketplace.

During this webinar, presenters will discuss a wide array of scalable dosage form technologies available. From tablet and multiparticulate forms to continuous and pulsatile release, esteemed scientists from Bend Research will discuss strategies in dosage design. As well, this webinar will pay particular focus on matching technology strengths with API properties and how to bring the array of choices together through biological modeling.

A Q&A with the presenters, Chris Craig, Director of Dosage Form Product Development, Bend Research, Inc., and Brett Caldwell, Ph.D., Director of Formulation Science, Bend Research, Inc., will follow the main presentation.

For more information about this event or to register, visit: http://www.xtalks.com/rational-design-of-modified-release-dosage-forms.ashx
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11060500.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
2. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
3. Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. PharmAthene Reports Year-End 2012 Financial And Operational Results
6. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
7. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
8. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
9. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
10. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , ... April 27, 2016 , ... Cambridge Semantics, ... semantic web technology, today announced that it has been named to The Silicon Review’s ... financial services and other markets, Cambridge Semantics serves the needs of end users facing ...
(Date:4/27/2016)... ... 2016 , ... The Pittcon Organizing Committee is pleased to announce that Charles ... member of Committee since 1987. Since then, he has served in a number of ... chairman for both the program and exposition committees. In his professional career, Dr. Gardner ...
(Date:4/27/2016)... VANCOUVER, British Columbia , April 27, 2016 ... "Gesellschaft" oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... sie im Anschluss an ihre Pressemitteilung vom 13. ... Inc. erhalten hat, ihre Finanzen um zusätzliche 200.000.000 ... auf 4.000.000 Kanadische Dollar zu bringen. Davon wurden ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... is pleased to announce the appointment of John Tilton as Chief Commercial Officer.  ... Director and one of the founding commercial leaders responsible for the commercialization of ...
Breaking Biology Technology:
(Date:3/9/2016)... Fla. , March 9, 2016  Crossmatch ... authentication and enrollment solutions, today announced the addition ... ® Altus multi-factor authentication platform. New ... InfoSec managers to step-up security where it,s needed ... Washington, DC . --> ...
(Date:3/3/2016)... SOTO, Kansas , March 3, 2016 ... Oncimmune,s Early CDT®-Lung, a blood test to aid ... cancer Early CDT®-Lung test to its clients ... Early CDT®-Lung test to its clients which include ... a leader in early cancer detection, today announced a ...
(Date:3/1/2016)...  (RSAC Booth #3041) – True fraud costs business ... is lost to false positives, where good customers are ... At the RSA Conference 2016, NuData Security is calling for ... by devaluing the data fraudsters have in abundance in ... --> --> Cheap and readily ...
Breaking Biology News(10 mins):